Jul 17, 2007
1:15
For every 15 shares held, investors received 1. The price per share adjusted from $0.26 to $3.83.
The split itself did not change the total investment value.
Canopus Biopharma, Inc. (OTC:CBIA) operates in the Pharmaceuticals: major industry.
Canopus Biopharma, Inc. company overviewCanopus Biopharma, Inc.'s most recent stock split was on July 17, 2007. It was a 1-for-15 reverse split, so shareholders received 1 share for every 15 they held.
Canopus Biopharma, Inc. has split its stock once. This history records one reverse split, on July 17, 2007.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Canopus Biopharma, Inc.'s 1-for-15 reverse split on July 17, 2007, every 15 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Canopus Biopharma, Inc. has not announced a new split in our records. Its most recent split was on July 17, 2007, 19 years ago. Companies announce splits in advance, and any new OTC:CBIA split will appear on this page.